What, Why and How – Technology & Market of Antiviral Coatings Additives

As the world grapples with the impact of COVID-19 and with fears of second and third waves of the pandemic, antiviral, antimicrobial surface coatings are being explored by paint and coatings manufacturers, researchers, and different stakeholders in order to strive prevention of similarly transmission of the disease. Recent research has proven that Coronaviruses can live on metal, glass and different surfaces for a long term depending on different factors like temperature, surface material, the unique stress of the virus etc. While the virus requires a living host to reproduce and thrive, indirect touch with the virus through contaminated surfaces is a primary factor of concern.

Having detailed research about the threads & Opportunities may lead you to a better position to target.

  • Chemical Structure/Sequence Search
  • Technology Scouting
  • Infringement Search
  • FTO or Clearance Search for your Product
  • Portfolio Analysis
  • Top Players in the market
Report

What, Why and How – Technology & Market of Antiviral Coatings Additives

What, Why and How – Technology & Market of Antiviral Coatings Additives

Download the Report

Send download link to:

About TTC
We’ve constantly identified the value of new technology carried out by our pretty skilled executive crew with backgrounds as our professionals. Like the IP professionals we empower, our starvation for development is never-ending. We IMPROVISE, ADAPT, and IMPLEMENT in a strategic manner.
 
You also can Contact Us to set up a consultation.
 
TT Consultants offers a range of efficient, high-quality solutions for your intellectual property management ranging from Patentability SearchInvalidation SearchFTO (Freedom to Operate)Patent Portfolio OptimizationPatent MonitoringPatent Infringement SearchPatent Drafting & Illustrations, and much more. We provide both law firms and corporations in many industries with turnkey solutions.
Insights

More Related Articles

protein sequence analysis biotechnology

Sequence-Based Freedom-to-Operate for a Clinical-Stage Antibody

The Patent That Looked Non-Essential – Until We Decoded the Math

EV Patent Infringement Analysis for 3,500+ Patents with TT Consultants

How a Global EV Giant Converted 3,500+ Patents into Validated Infringement Intelligence in 6 Weeks